Abstract
In order to assess the importance of the intensity of administration of chemotherapy in the management of advanced germ cell tumours we have calculated indices of chemotherapy. These have been used to compare the treatment given to patients who subsequently relapsed with matched controls who did not relapse. Two of these indices (alpha and beta) are derived from the doses of drugs whose dose is varied (cisplatinum, methotrexate and etoposide). These indices showed significant variation between cases and controls. Indices gamma and delta are derived from drugs whose dose is not varied. They showed no significant differences between the two groups. These results emphasise the importance of ensuring that patients with these curable cancers receive adequate doses of chemotherapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crawford, S., Newlands, E., Begent, R. et al. The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy. Br J Cancer 59, 243–246 (1989). https://doi.org/10.1038/bjc.1989.49
Issue Date:
DOI: https://doi.org/10.1038/bjc.1989.49
This article is cited by
-
Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples
Cancer Chemotherapy and Pharmacology (1992)